Literature DB >> 10874201

Treatment of age-related macular degeneration.

.   

Abstract

Age-related macular degeneration (AMD), while rapidly becoming more prevalent due to an aging population, is still poorly understood and treatment modalities are limited. Fortunately, advances are being made in the treatment of AMD that may greatly alter the outcome of this debilitating disease. Treatments for both wet and dry AMD are reviewed.

Entities:  

Year:  2000        PMID： 10874201     DOI： 10.1016/s0953-4431(99)00043-0

Source DB:  PubMed          Journal:  Clin Eye Vis Care        ISSN： 0953-4431


  3 in total

1.  Identifying the proportion of age related macular degeneration patients who would benefit from photodynamic therapy with verteporfin (Visudyne).

Authors:  N Mandal; I H Chisholm
Journal:  Br J Ophthalmol       Date:  2002-01       Impact factor: 4.638

2.  Preventive versus treatment effect of AG3340, a potent matrix metalloproteinase inhibitor in a rat model of choroidal neovascularization.

Authors:  Mohammed El Bradey; Lingyun Cheng; Dirk-Uwe Bartsch; Krzystof Appelt; Nuttawut Rodanant; Germaine Bergeron-Lynn; William R Freeman
Journal:  J Ocul Pharmacol Ther       Date:  2004-06       Impact factor: 2.671

Review 3.  Verteporfin : a review of its use in the management of subfoveal choroidal neovascularisation.

Authors:  Susan J Keam; Lesley J Scott; Monique P Curran
Journal:  Drugs       Date:  2003       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.